Pediatric multiple sclerosis

Annals of Indian Academy of Neurology

Volumn 12, Issue 4, 2009, Pages 238-245

  Patel, Yashma ^a   Bhise, Vikram ^a   Krupp, Lauren ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pediatric multiple sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA1A INTERFERON; CORTICOSTEROID; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHYLPREDNISOLONE; NATALIZUMAB; OLIGOCLONAL BAND; PREDNISONE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; BLOOD CELL COUNT; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; DEMOGRAPHY; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENCEPHALITIS; ENCEPHALOMYELITIS; ENVIRONMENTAL EXPOSURE; ERYTHROCYTE SEDIMENTATION RATE; FLU LIKE SYNDROME; GROWTH DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INJECTION SITE REACTION; INSOMNIA; INTESTINE LIPODYSTROPHY; LABORATORY TEST; LEUKODYSTROPHY; LYME DISEASE; MENINGOENCEPHALITIS; MOOD DISORDER; MORNING DOSAGE; MULTIPLE SCLEROSIS; MYALGIA; MYELOOPTIC NEUROPATHY; NEUROSYPHILIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOSIS; PATHOGENESIS; PATIENT COMPLIANCE; PLASMAPHERESIS; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOSIS; QUALITY OF LIFE; RELAPSE; REVIEW; RISK; SIDE EFFECT; SOCIAL PSYCHOLOGY; SUBACUTE SCLEROSING PANENCEPHALITIS; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE;

EID: 72949089446     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.58281     Document Type: Review

References (70)

1. Duquette P, Murray TJ, Pleines J, Ebers GC, Sadovnick D, Weldon P, et al. Multiple sclerosis in childhood: Clinical profile in 125 patients. J Pediatr 1987;111:359-363
2. Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: A longitudinal study. Neurology 2002;59:1006-1010
3. Ghezzi A, Deplano V, Faroni J, Grasso MG, Liguori M, Marrosu G, et al. Multiple sclerosis in childhood: Clinical features of 149 cases. Mult Scler 1997;3:43-46
4. Sindern E, Haas J, Stark E, Wurster U. Early onset MS under the age of 16: Clinical and paraclinical features. Acta Neurol Scand 1992;86:280-284
5. Ruggieri M, Polizzi A, Pavone L, Grimaldi LM. Multiple sclerosis in children under 6 years of age. Neurology 1999;53:478-484
6. Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603-2613
7. Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, et al. Course and prognosis in early-onset MS: Comparison with adult-onset forms. Neurology 2002;59:1922-1928
8. Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatriconset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 2009;15:627-631
9. Compston A. McAlpine's multiple sclerosis. 3rd ed. London: Churchill Livingston; 1998.
10. Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232-239
11. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6:887-902.
12. Krupp L. Racial and ethnic FIndings in pediatric MS: An update. Neurology 2008;S70:A135.
13. Kennedy J, O'Connor P, Sadovnick AD, Perara M, Yee I, Banwell B. Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology 2006;26:162-167
14. Deryck EA. Clinical characteristics and long term prognosis in early onset multiple sclerosis. J Neurol 2006;252:720-723
15. Mikaeloff Y, Suissa S, Vallee L, Lubetzki C, Ponsot G, Confavreux C, et al. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246-252
16. Neuteboom RF, Boon M, Catsman Berrevoets CE, Vles JS, Gooskens RH, Stroink H, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008;71:967-973
17. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-2422
18. Dale RC, Pillai SC. Early relapse risk after a first CNS inflammatory demyelination episode: Examining international consensus definitions. Dev Med Child Neurol 2007;49:887-893
19. Bonhomme GR, Waldman AT, Balcer LJ, Daniels AB, Tennekoon GI, Forman S, et al. Pediatric optic neuritis: Brain MRI abnormalities and risk of multiple sclerosis. Neurology 2009;72:881-885
20. Lucchinetti CF, Kiers L, O'Duffy A, Gomez MR, Cross S, Leavitt JA, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997;49:1413-1418
21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127
22. Mikaeloff Y, Adamsbaum C, Husson B, Vallee L, Ponsot G, Confavreux C, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004;127:1942-1947
23. Callen DJ, Shroff MM, Branson HM, Lotze T, Li DK, Stephens D, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology 2009;72:961-967
24. Ozakbas S, Idiman E, Baklan B, Yulug B. Childhood and juvenile onset multiple sclerosis: Clinical and paraclinical features. Brain Dev 2003;25:233-236
25. Ghezzi A, Pozzilli C, Liguori M, Marrosu MG, Milani N, Milanese C, et al. Prospective study of multiple sclerosis with early onset. Mult Scler 2002;8:115-118
26. Gusev E, Boiko A, Bikova O, Maslova O, Guseva M, Boiko S, et al. The natural history of early onset multiple sclerosis: Comparison of data from Moscow and Vancouver. Clin Neurol Neurosurg 2002;104:203-207
27. Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse. Eur J Paediatr Neurol 2007;11:90-95
28. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, et al. Clinical features and viral serologies in children with multiple sclerosis: A multinational observational study. Lancet Neurol 2007;6:773-781
29. Pohl D, Rostasy K, Treiber-Held S, Brockmann K, Gartner J, Hanefeld F. Pediatric multiple sclerosis: Detection of clinically silent lesions by multimodal evoked potentials. J Pediatr 2006;149:125-127
30. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224-1231
31. Castillo T, Chabas D, Waubant E. MS Onset before puberty: A distinct MRI. Neurology 2008;70:A134.
32. Mikaeloff Y, Caridade G, Assi S, Suissa S, Tardieu M. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics 2006;118:1133-1139
33. MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005;64:1422-1425
34. Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology 2005;64:891-894
35. Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008;70:1891-1897
36. Amato M. Cognitive and psychosocial features of childhood and juvenile multiple sclerosis: A reappraisal after 2 years. Neurology 2009;3:A97.
37. Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu G, Martinelli V, et al. Disease-modifying drugs in childhood-juvenile multiple sclerosis: Results of an Italian co-operative study. Mult Scler 2005;11:420-424 (Pubitemid 40984236)
38. Pohl D, Rostasy K, Gartner J, Hanefeld F. Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 2005;64:888-890
39. Chitnis T. Pediatric multiple sclerosis. Neurologist 2006;12:299-310.
40. Hahn JS, Pohl D, Rensel M, Rao S. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology 2007;686:S13-22.
41. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 2007;686:S23-36.
42. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;686:S7-12.
43. Brass SD, Caramanos Z, Santos C, Dilenge ME, Lapierre Y, Rosenblatt B. Multiple sclerosis vs acute disseminated encephalomyelitis in childhood. Pediatr Neurol 2003;29:227-231
44. Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology 2009;72:968-973
45. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-1312
46. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344-352
47. Hahn CD, Shroff MM, Blaser SI, Banwell BL. MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology 2004;62:806-808
48. Van der Knaap MS. Magnetic resonance of myelination and myelin disorders. 3rd ed: Springer; 2005.
49. Gorman MP, Golomb MR, Walsh LE, Hobson GM, Garbern JY, Kinkel RP, et al. Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation. Neurology 2007;68:1305-1307
50. Barnes D, Hughes RA, Morris RW, Wade-Jones O, Brown P, Britton T, et al. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet 1997;34905:902-906 (Pubitemid 27139818)
51. Martinelli V, Pulizzi A, Annovazzi P, Rocca M, Rodegher M. A short-term MRI study comparing high-dose oral versus intravenous methylpredisolone in MS relapse. Neurology 2008;70:A83-4.
52. Morrow SA, Stoian CA, Dmitrovic J, Chan SC, Metz LM. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology 2004;63:1079-1080
53. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999;46:878-886
54. Duzova A, Bakkaloglu A. Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment. Curr Pharm Des 2008;14:1295-1301
55. Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996;46:1173-1174
56. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol 1999;21:583-586
57. Mikaeloff Y, Caridade G, Tardieu M, Suissa S. Effectiveness of early beta interferon on the first attack after conFIrmed multiple sclerosis: A comparative cohort study. Eur J Paediatr Neurol 2008;12:205-209
58. Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu MG, Martinelli V, et al. Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: Long-term results. Neurol Sci 2007;28:127-132
59. Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, et al. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 2001;32:211-213
60. Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, et al. Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 2001;139:443-446 (Pubitemid 32889524)
61. Tenembaum SN, Segura MJ. Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology 2006;67:511-513
62. Banwell B, Reder AT, Krupp L, Tenembaum S, Eraksoy M, Alexey B, et al. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 2006;66:472-476
63. Adams AB, Tyor WR, Holden KR. Interferon beta-1b and childhood multiple sclerosis. Pediatr Neurol 1999;21:481-483
64. Kornek B, Bernert G, Balassy C, Geldner J, Prayer D, Feucht M. Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics 2003;34:120-126
65. Yeh A. Breakthrough disease in pediatric MS patients: A pediatric network experience. Multiple Sclerosis in press.
66. Makhani N, Gorman MP, Branson HM, Stazzone L, Banwell BL, Chitnis T. Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology 2009;72:2076-2082
67. Borriello G, Prosperini L, Luchetti A, Pozzilli C. Natalizumab treatment in pediatric multiple sclerosis: A case report. Eur J Paediatr Neurol 2009;13:67-71.
68. Huppke P, Stark W, Zurcher C, Huppke B, Bruck W, Gartner J. Natalizumab use in pediatric multiple sclerosis. Arch Neurol 2008;65:1655-1658
69. Hoving MA, van Raak EP, Spincemaille GH, van Kranen-Mastenbroek VH, van Kleef M, Gorter JW, et al. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol 2009;13:247-256
70. Brochard S, Remy-Neris O, Filipetti P, Bussel B. Intrathecal baclofen infusion for ambulant children with cerebral palsy. Pediatr Neurol 2009;40:265-270